FAAH and Alzheimer disease: Meanwhile, pharmacological inhibition of FAAH had little effect on cognitive impairment, plaque deposition or inflammatory markers in 5xFAD mice [135], indicating that the pharmacological enhancement of anandamide levels – in contrast to 2-AG enhancement – does little to improve symptoms of AD in this particular mouse model.